ORPP logo
Image from Google Jackets

Dystonia 4.

By: Contributor(s): Material type: TextTextSeries: Advances in NeurologyPublisher: Philadelphia : Wolters Kluwer Health, 2003Copyright date: ©2003Edition: 1st edDescription: 1 online resource (368 pages)Content type:
  • text
Media type:
  • computer
Carrier type:
  • online resource
ISBN:
  • 9781469877310
Subject(s): Genre/Form: Additional physical formats: Print version:: Dystonia 4DDC classification:
  • 616.8
LOC classification:
  • RC935.D8 -- .D978 2004eb
Online resources:
Contents:
Intro -- Contents -- Contributing Authors -- Preface -- Acknowledgments -- I: Pathophysiology -- 1 Dystonia: Abnormal Movements Result from Loss of Inhibition -- 2 Sensory Deficits in Dystonia and Their Significance -- 3 Focal Hand Dystonia May Result from Aberrant Neuroplasticity -- 4 Basal Ganglia Neuronal Discharge in Primary and Secondary Dystonia -- 5 Evidence of Widespread Impairment of Motor Cortical Inhibition in Focal Dystonia: A Transcranial Magnetic Stimulation Study in -- 6 Modulation of Cortical Activity by Repetitive Transcranial Magnetic Stimulation (rTMS): A Review of Functional Imaging Studies -- II: Oppenheim's Dystonia -- 7 Dopamine Transmission in DYT1 Dystonia -- 8 Development and Anatomic Localization of TorsinA -- 9 Mouse Models of TorsinA Dysfunction -- 10 Dominant TorsinA Mutations in Cellular Systems -- 11 An Animal Model to Discern Torsin Function: Suppression of Protein Aggregation in -- 12 TorsinA and Early-Onset Torsion Dystonia -- 13 An Epidemiologic Survey of Dystonia Within the Entire Population of Northeast England Over the Past Nine Years -- III: Other Genetic Disorders -- 14 Dystonia Genotypes, Phenotypes, and Classification -- 15 Update on the Genetics of Primary Torsion Dystonia Loci -- and -- and the Dystonia-Plus Locus -- 16 Inherited Myoclonus-Dystonia -- 17 Penetrance and Expression of Dystonia Genes -- 18 Update on Dopa-Responsive Dystonia: Locus Heterogeneity and Biochemical Features -- 19 X-Linked Recessive Dystonia Parkinsonism (XDP -- Lubag -- DYT3) -- 20 Focal Dystonia Is Associated with a Polymorphism of the Dopamine D5 Receptor Gene -- 21 Dystonia With and Without Deafness Is Caused by TIMM8A Mutation -- IV: PET and Biochemistry of Dystonia -- 22 Abnormal Brain Networks in Primary Torsion Dystonia -- 23 Dysfunction of Dopaminergic Pathways in Dystonia.
24 Clinical Presentation and Progression of Sporadic and Familial Primary Torsion Dystonia in Italy -- 25 Cognition and Affect in Patients with Cervical Dystonia With and Without Tremor -- 26 Clinical Features of the -- in Cervical Dystonia -- 27 Executive Function in Dystonia -- 28 Duration of Effectiveness of Botulinum Toxin Type B in the Treatment of Cervical Dystonia -- 29 Is Phenotypic Variation of Hereditary Progressive Dystonia with Marked Diurnal Fluctuation/Dopa-Responsive Dystonia (HPD/DRD) -- V: Musicians' and Other Focal Dystonias -- 30 Focal Task-Specific Dystonia in Musicians -- 31 Brain Mapping in Musicians with Focal TaskSpecific Dystonia -- 32 Three-Dimensional Movement Analysis as a Promising Tool for Treatment Evaluation of Musicians' Dystonia -- 33 Limb Immobilization for Occupational Dystonia: A Possible Alternative Treatment for Selected Patients -- 34 Review of 113 Musicians with Focal Dystonia Seen Between 1985 and 2002 at a Clinic for Performing Artists -- 35 The Impact of Focal Dystonia on the Working Life of Musicians in the United Kingdom -- 36 Long-Term Outcome of Focal Dystonia in Instrumental Musicians -- 37 Abnormal Sensorimotor Processing in Pianists with Focal Dystonia -- VI: Therapeutics -- 38 Dystonia: Medical Therapy and Botulinum Toxin -- 39 Pallidotomy for Generalized Dystonia -- 40 Pallidal Stimulation for Dystonia -- 41 Off-Period Dystonia in Parkinson's Disease but Not Generalized Dystonia Is Improved By High-Frequency Stimulation of the Subt -- 42 Autonomic Side Effects of Botulinum Toxin Type B Therapy -- 43 Dystonia and Headaches: Clinical Features and Response to Botulinum Toxin Therapy -- 44 Rating Scales for Dystonia: Assessment of Reliability of Three Scales -- Subject Index.
Summary: Written by leading international experts in all relevant clinical and basic science disciplines, Dystonia 4 is a state-of-the-art review of recent progress in the understanding and treatment of the dystonias. It provides a comprehensive update on the many breakthroughs that have occurred in the five years since the highly acclaimed Dystonia 3 was published. The therapeutics section features detailed discussions on botulinum toxin treatment and current surgical procedures. The book also includes a major section on recent advances in understanding the genetics of the dystonias. Other sections focus on pathophysiology, Oppenheim's dystonia, PET and biochemical studies, and musician's and other focal dystonias.
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Intro -- Contents -- Contributing Authors -- Preface -- Acknowledgments -- I: Pathophysiology -- 1 Dystonia: Abnormal Movements Result from Loss of Inhibition -- 2 Sensory Deficits in Dystonia and Their Significance -- 3 Focal Hand Dystonia May Result from Aberrant Neuroplasticity -- 4 Basal Ganglia Neuronal Discharge in Primary and Secondary Dystonia -- 5 Evidence of Widespread Impairment of Motor Cortical Inhibition in Focal Dystonia: A Transcranial Magnetic Stimulation Study in -- 6 Modulation of Cortical Activity by Repetitive Transcranial Magnetic Stimulation (rTMS): A Review of Functional Imaging Studies -- II: Oppenheim's Dystonia -- 7 Dopamine Transmission in DYT1 Dystonia -- 8 Development and Anatomic Localization of TorsinA -- 9 Mouse Models of TorsinA Dysfunction -- 10 Dominant TorsinA Mutations in Cellular Systems -- 11 An Animal Model to Discern Torsin Function: Suppression of Protein Aggregation in -- 12 TorsinA and Early-Onset Torsion Dystonia -- 13 An Epidemiologic Survey of Dystonia Within the Entire Population of Northeast England Over the Past Nine Years -- III: Other Genetic Disorders -- 14 Dystonia Genotypes, Phenotypes, and Classification -- 15 Update on the Genetics of Primary Torsion Dystonia Loci -- and -- and the Dystonia-Plus Locus -- 16 Inherited Myoclonus-Dystonia -- 17 Penetrance and Expression of Dystonia Genes -- 18 Update on Dopa-Responsive Dystonia: Locus Heterogeneity and Biochemical Features -- 19 X-Linked Recessive Dystonia Parkinsonism (XDP -- Lubag -- DYT3) -- 20 Focal Dystonia Is Associated with a Polymorphism of the Dopamine D5 Receptor Gene -- 21 Dystonia With and Without Deafness Is Caused by TIMM8A Mutation -- IV: PET and Biochemistry of Dystonia -- 22 Abnormal Brain Networks in Primary Torsion Dystonia -- 23 Dysfunction of Dopaminergic Pathways in Dystonia.

24 Clinical Presentation and Progression of Sporadic and Familial Primary Torsion Dystonia in Italy -- 25 Cognition and Affect in Patients with Cervical Dystonia With and Without Tremor -- 26 Clinical Features of the -- in Cervical Dystonia -- 27 Executive Function in Dystonia -- 28 Duration of Effectiveness of Botulinum Toxin Type B in the Treatment of Cervical Dystonia -- 29 Is Phenotypic Variation of Hereditary Progressive Dystonia with Marked Diurnal Fluctuation/Dopa-Responsive Dystonia (HPD/DRD) -- V: Musicians' and Other Focal Dystonias -- 30 Focal Task-Specific Dystonia in Musicians -- 31 Brain Mapping in Musicians with Focal TaskSpecific Dystonia -- 32 Three-Dimensional Movement Analysis as a Promising Tool for Treatment Evaluation of Musicians' Dystonia -- 33 Limb Immobilization for Occupational Dystonia: A Possible Alternative Treatment for Selected Patients -- 34 Review of 113 Musicians with Focal Dystonia Seen Between 1985 and 2002 at a Clinic for Performing Artists -- 35 The Impact of Focal Dystonia on the Working Life of Musicians in the United Kingdom -- 36 Long-Term Outcome of Focal Dystonia in Instrumental Musicians -- 37 Abnormal Sensorimotor Processing in Pianists with Focal Dystonia -- VI: Therapeutics -- 38 Dystonia: Medical Therapy and Botulinum Toxin -- 39 Pallidotomy for Generalized Dystonia -- 40 Pallidal Stimulation for Dystonia -- 41 Off-Period Dystonia in Parkinson's Disease but Not Generalized Dystonia Is Improved By High-Frequency Stimulation of the Subt -- 42 Autonomic Side Effects of Botulinum Toxin Type B Therapy -- 43 Dystonia and Headaches: Clinical Features and Response to Botulinum Toxin Therapy -- 44 Rating Scales for Dystonia: Assessment of Reliability of Three Scales -- Subject Index.

Written by leading international experts in all relevant clinical and basic science disciplines, Dystonia 4 is a state-of-the-art review of recent progress in the understanding and treatment of the dystonias. It provides a comprehensive update on the many breakthroughs that have occurred in the five years since the highly acclaimed Dystonia 3 was published. The therapeutics section features detailed discussions on botulinum toxin treatment and current surgical procedures. The book also includes a major section on recent advances in understanding the genetics of the dystonias. Other sections focus on pathophysiology, Oppenheim's dystonia, PET and biochemical studies, and musician's and other focal dystonias.

Description based on publisher supplied metadata and other sources.

Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries.

There are no comments on this title.

to post a comment.

© 2024 Resource Centre. All rights reserved.